Hendrik W. van Deventer

University of North Carolina at Chapel Hill — United States

Immunology and Microbiology · Life Sciences

15h-index1.1kcitations66works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune cells in cancer(26), Inflammation biomarkers and pathways(18), Acute Myeloid Leukemia Research(14), Phagocytosis and Immune Regulation(12), Inflammasome and immune disorders(10)

Publications66 total

Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.
UNC Libraries·2025Open Access
Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report
Journal of Medical Case Reports·2023· 3 citedOpen Access
Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
The Journal of Immunology·2023· 15 citedOpen Access
Data from C-C Chemokine Receptor 5 on Pulmonary Mesenchymal Cells Promotes Experimental Metastasis via the Induction of Erythroid Differentiation Regulator 1
2023Open Access
Supplementary Procedures and Supplementary Figures 1 through 3 from C-C Chemokine Receptor 5 on Pulmonary Mesenchymal Cells Promotes Experimental Metastasis via the Induction of Erythroid Differentiation Regulator 1
2023Open Access
Data from C-C Chemokine Receptor 5 on Pulmonary Mesenchymal Cells Promotes Experimental Metastasis via the Induction of Erythroid Differentiation Regulator 1
2023Open Access
Supplementary Procedures and Supplementary Figures 1 through 3 from C-C Chemokine Receptor 5 on Pulmonary Mesenchymal Cells Promotes Experimental Metastasis via the Induction of Erythroid Differentiation Regulator 1
2023Open Access
Supplementary Figure Legends 1-7 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
2023Open Access
Supplementary Figure 4 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
2023Open Access
Supplementary Figure 3 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
2023Open Access
Supplementary Figure 5 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
2023Open Access
Supplementary Figure 7 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
2023· 1 citedOpen Access
Supplementary Figure 5 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
2023Open Access
Supplementary Figure 3 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
2023· 1 citedOpen Access
Supplementary Figure 6 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
2023Open Access
Supplementary Figure 1 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
2023Open Access
Data from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
2023Open Access
Data from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
2023Open Access
Supplementary Figure 6 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
2023Open Access
Supplementary Figure 7 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Jonathan S. Serody(34), Qing Ping Wu(18), W. June Brickey(17), Joseph E. Burgents(15), Rita-Marie T. Woodford(15), Erin McElvania(15), Jenny P.‐Y. Ting(14), Matthew C. Foster(10), Irving C. Allen(10), Qing Wu(8), E.C. McCook(7), Katarzyna Jamieson(7), Joshua F. Zeidner(7), Robert L. Mango(7), Anastasia Ivanova(6), Jenny P.‐Y. Ting(6), Michelle L. West(6), Thomas C. Shea(5), Irving C. Allen(5), Peter M. Voorhees(4)